Besides being an important player in bone metabolism, OPG is a key regulator in vascular disease, prostate cancer, multiple myeloma, breast cancer, bladder carcinoma, and gastric carcinoma [4]. The gene discussed is TNFRSF11B; the disease is plasma cell myeloma.